• Careers
  • Apply
  • Events
    • Global
    • Local
  • News
  • Contact
  • Careers
  • Apply
  • Events
    • Global
    • Local
  • News
  • Contact
14
Mar

The remaining gaps in evidence for cardiac CT

Cardiac, CT
The ACC/AHA 2021 Chest Pain Assessment Guidelines boosted coronary computed tomography angiography (CCTA) to a Class 1A level of clinical evidence and helped significantly boost interest in building or expanding cardiac CT programs in the past year. While Cardiac CTA does have a large amount of clinical study support, there are some gaps remaining yet to be filled.
PrevNext

Related Posts

March 23, 2023

FDA clears new AI-powered cardiac imaging solution

increaseoNews0
March 16, 2023

Cardiac imagers need to understand AI as it enters clinical use and ACC guidelines

increaseoNews0
February 25, 2023

AI Tool Forecasts Lung Cancer Risk From a Single CT Scan

increaseoNews0

Latest News

  • 5 key trends in PACS and enterprise imaging from Signify Research
  • Advanced PET/MRI protocols boost lung cancer detection
  • FDA clears new AI-powered cardiac imaging solution

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.

RSS Health Pulse

  • Is 'climate anxiety' a clinical diagnosis? Should it be?
  • What causes hiccups and how can you get rid of them?
  • TGA review strengthens case for much tighter vape restrictions at the border

Twitter

  • Amy Thompson, a senior analyst at Signify Research, explains what she is seeing in the market for radiology PACS an… https://t.co/rPyNpufEmG 12 hours ago
  • PET/MRI achieves similar or superior results to PET/CT for the detection of pulmonary malignancies, according to ne… https://t.co/xreCTlkiok 3 days ago
  • DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. FDA clearance for LVivo IQS, a… https://t.co/14Y4F4TGMP 5 days ago
© GCG Global Healthcare Pty Ltd, All rights reserved. ABN 25 136 716 991

Find your next opportunity with
GCG Global Healthcare TODAY!

DISCOVER OUR OPEN POSITIONS NOW!